CLINICAL_TRIALS trial_result · 2018-12-28

Clinical Trial Update: A Study of LY2940680 in Small Cell Lung Cancer [Phase 1, Phase 2]

A Phase 1/2 trial of LY2940680 in small cell lung carcinoma was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-12-28